IRIS UniCatt

Ferrandina, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.275
NA - Nord America 8.827
AS - Asia 4.313
SA - Sud America 886
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 13
Totale 23.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.705
DE - Germania 2.683
SE - Svezia 1.733
CN - Cina 1.630
SG - Singapore 1.500
IT - Italia 1.090
BR - Brasile 803
FR - Francia 712
UA - Ucraina 699
PL - Polonia 646
IE - Irlanda 494
IN - India 386
GB - Regno Unito 360
ID - Indonesia 303
FI - Finlandia 240
RU - Federazione Russa 238
TR - Turchia 114
BE - Belgio 74
CA - Canada 74
NL - Olanda 62
AT - Austria 50
CI - Costa d'Avorio 50
HK - Hong Kong 47
VN - Vietnam 44
JP - Giappone 41
IR - Iran 39
KR - Corea 36
LT - Lituania 29
BD - Bangladesh 27
ES - Italia 26
CZ - Repubblica Ceca 25
AR - Argentina 24
MX - Messico 22
RO - Romania 21
EU - Europa 16
MA - Marocco 16
CH - Svizzera 15
EC - Ecuador 15
PK - Pakistan 15
AE - Emirati Arabi Uniti 13
CO - Colombia 12
IQ - Iraq 12
SA - Arabia Saudita 12
PH - Filippine 11
ZA - Sudafrica 11
AU - Australia 10
CL - Cile 10
GR - Grecia 10
IL - Israele 10
UZ - Uzbekistan 10
DZ - Algeria 9
EG - Egitto 9
HR - Croazia 9
PA - Panama 9
HU - Ungheria 8
PE - Perù 8
BH - Bahrain 7
KZ - Kazakistan 7
KG - Kirghizistan 6
LV - Lettonia 6
MD - Moldavia 6
MT - Malta 6
AZ - Azerbaigian 5
JM - Giamaica 5
JO - Giordania 5
NO - Norvegia 5
PY - Paraguay 5
RS - Serbia 5
VE - Venezuela 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
KE - Kenya 4
MY - Malesia 4
PT - Portogallo 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
DK - Danimarca 3
EE - Estonia 3
KW - Kuwait 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
OM - Oman 3
TJ - Tagikistan 3
TW - Taiwan 3
A1 - Anonimo 2
BO - Bolivia 2
BZ - Belize 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NP - Nepal 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BY - Bielorussia 1
Totale 23.433
Salva come PNG Salva come JPEG
Città #
Chandler 1.886
Singapore 850
Ashburn 639
Warsaw 580
Dublin 479
Jacksonville 442
San Mateo 408
Wilmington 312
Jakarta 296
Nanjing 270
New York 247
Hangzhou 238
Ann Arbor 223
Beijing 199
Rome 196
Houston 191
Dearborn 177
Hyderabad 176
Boston 168
Fairfield 158
Nürnberg 149
Milan 144
Moscow 143
Woodbridge 140
Princeton 139
Cattolica 138
Marseille 125
Lawrence 121
Seattle 116
The Dalles 111
Redwood City 104
Frankfurt am Main 98
Los Angeles 90
Bremen 85
Nanchang 83
Helsinki 78
Izmir 75
Brussels 69
Munich 69
São Paulo 69
Boardman 62
Cambridge 61
Leawood 60
Hefei 58
Lancaster 57
Zhengzhou 57
University Park 54
Strasbourg 53
London 51
Mountain View 51
Abidjan 50
Kraków 47
Norwalk 47
Kunming 46
Düsseldorf 43
Changsha 42
Chicago 42
Detroit 42
Hebei 42
Shenyang 42
Redmond 41
Jiaxing 39
Augusta 35
Seoul 35
Shanghai 34
Toronto 34
Hong Kong 33
Nuremberg 33
Guangzhou 32
Tianjin 32
Andover 31
Pune 29
Vienna 29
Fremont 27
Belo Horizonte 25
San Francisco 24
Lauterbourg 23
San Jose 20
Amsterdam 19
Edinburgh 18
Rio de Janeiro 18
Turku 18
Naples 17
Washington 17
Wroclaw 17
Brooklyn 15
Palermo 15
Simi Valley 15
Bexley 14
Brasília 14
Jinan 14
Menlo Park 14
Ottawa 14
Santa Clara 14
Busto Arsizio 13
Falkenstein 13
Lanzhou 13
Paris 13
Hanoi 12
Phoenixville 12
Totale 12.173
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 813
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 461
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study 360
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 324
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 323
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 267
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 257
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 200
I nuovi mezzi di contrasto nello studio delle patologie ginecologiche. Applicazioni diagnostiche e prospettive terapeutiche. 195
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 184
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 184
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 178
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 177
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 176
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo? 162
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 156
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 156
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. 152
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 150
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 149
Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. 148
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 147
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 143
Sonographic imaging of urinoma 140
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 140
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 136
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 136
Ultrasound contrast examination to discriminate benign and malignant adnexal masses 135
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 135
A case of isolated ovarian recurrence from vulvar carcinoma. 134
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 132
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 128
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 127
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 126
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 126
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 125
Color Doppler sonographic features of a Krukenberg tumor in pregnancy 124
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 123
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 121
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 120
Neuroendocrine stress response in patients undergoing benign ovarian cyst surgery by laparoscopy, minilaparotomy, and laparotomy 120
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 118
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 117
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 117
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 116
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 116
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 116
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 114
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 113
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 110
Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature 110
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 110
Preoperative local-regional staging of endometrial cancer: transvaginal sonography versus magnetic resonance imaging 109
Female pelvis 109
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries. 109
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 106
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review 106
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 105
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 104
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 101
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 100
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 100
Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report. 99
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. 99
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 98
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 98
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 97
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 97
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 96
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 96
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial 96
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 94
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 94
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 94
Epidermal growth factor levels in human breast cyst fluid 93
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 93
Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wall 92
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 90
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 89
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma 89
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 89
Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database 89
ASO Author Reflections: Conization Before Radical Hysterectomy Improves Disease-Free Survival in Early Stage Cervical Cancer 89
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 88
Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer 88
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients 87
Epidermal growth factor levels in human breast cyst fluid 87
A whole germline BRCA2 gene deletion: How to learn from CNV in silico analysis 87
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 87
Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series 86
Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy 85
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study 85
L'ecografia tridimensionale in ginecologia: indicazioni, limiti e nuovi sviluppi in ginecologia. Working progress. 84
Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy 84
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 84
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 84
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups 84
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 83
Long-term survival of young endometrial cancer patients desiring fertility preservation treated with hysteroscopic resection followed by hormone therapy (NEMO technique) 83
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 83
Totale 13.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020251 0 0 0 0 0 0 0 0 0 0 0 251
2020/20212.242 141 199 87 238 299 102 266 64 208 182 363 93
2021/20222.589 285 157 47 257 122 68 46 407 108 192 390 510
2022/20235.190 694 712 411 785 345 631 225 387 628 138 156 78
2023/20242.476 100 729 67 157 74 320 178 87 47 98 319 300
2024/20255.200 134 136 397 187 489 180 231 246 834 675 1.058 633
Totale 24.717